Erector Spinae Plane Block for Post-thoracotomy Pain Control
CompletedNot applicableNCT04531553
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The thoracic epidural block (TEB) and thoracic paravertebral block (TPVB) are the most commonly used techniques for analgesia after thoracic surgery.Recently, erector spinae plane block (ESPB) was reported as a treatment for thoracic neuropathic pain.Dexmedetomidine has been primarily used for intra- venous sedation in intensive care settings. The unique analgesic properties of dexmedetomidine have encouraged the anesthesiologists to use it perineurally. This study aims to evaluate the effect ultrasound erector spinae plane block with dexmedetomidine infusion in management of acute and chronic post thoracotomy pain.
Study details
- Official title
- The Impact of Ultrasound-Guided Erector Spinae Plane Block Versus Thoracic Epidural Analgesia in the Management of Acute and Chronic Post-Thoracotomy Pain: A Randomized, Controlled Study
- Conditions
- Post-thoracotomy Pain Syndrome
- Interventions
- Procedure: Thoracic epidural analgesia
- Procedure: ESPB with levobupivacaine and dexmedetomedine
- Procedure: ESPB with levobupivacaine
- Sponsor
- National Cancer Institute, Egypt
- Start date
- 2021-03-03
- Primary completion
- 2022-05-28
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Physical status ASA I and II. * Age ≥ 18 and ≤ 65 Years. * Body mass index (BMI): \> 20 kg/m2 and \< 40 kg/m2. * Patient undergoing thoracotomy for cancer surgery (Lobectomy, Pneumonectomy, and Decortication). Exclusion Criteria: * Patient refusal * Known sensitivity or contraindication to local anesthetics or dexmedetomidine. * History of psychological disorders. * Localized infection at the site of block. * Coagulopathies with platelet count below 50,000 or an INR\>1.5.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04531553